VOLITIONRX LTD — Director's Dealing 2015

Sep 15, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2015-05-18

Reporting Person: Colman Alan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-18	Option (Right to Buy)	$3	D	5000	Disposed	2015-05-25	Common Stock (5000)	Direct
2015-05-18	Option (Right to Buy)	$3	D	5000	Disposed	2015-11-25	Common Stock (5000)	Direct
2015-05-18	Option (Right to Buy)	$4	D	5000	Disposed	2016-05-25	Common Stock (5000)	Direct
2015-05-18	Option (Right to Buy)	$4	D	5000	Disposed	2016-11-25	Common Stock (5000)	Direct
2015-05-18	Option (Right to Buy)	$5	D	5000	Disposed	2017-05-25	Common Stock (5000)	Direct
2015-05-18	Option (Right to Buy)	$5	D	5000	Disposed	2017-11-25	Common Stock (5000)	Direct
2015-05-18	Option (Right to Buy)	$3	A	5000	Acquired	2016-05-25	Common Stock (5000)	Direct
2015-05-18	Option (Right to Buy)	$3	A	5000	Acquired	2016-11-25	Common Stock (5000)	Direct
2015-05-18	Option (Right to Buy)	$4	A	5000	Acquired	2017-05-25	Common Stock (5000)	Direct
2015-05-18	Option (Right to Buy)	$4	A	5000	Acquired	2017-11-25	Common Stock (5000)	Direct
2015-05-18	Option (Right to Buy)	$5	A	5000	Acquired	2018-05-25	Common Stock (5000)	Direct
2015-05-18	Option (Right to Buy)	$5	A	5000	Acquired	2018-11-25	Common Stock (5000)	Direct

Footnotes

F1: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on November 25, 2011 and fully-vested on November 25, 2014, and were exercisable for three years from the date first exercisable. The "replacement" options are fully-vested and exercisable for a period of four years from the date first exercisable.